Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T88015 | Target Info | |||
Target Name | COVID-19 3C-like protease (3CLpro) | ||||
Synonyms | COVID-19 3CL-PRO; COVID-19 3CLp; COVID-19 nsp5 | ||||
Gene Name | COVID-19 rep | ||||
Biochemical Class | Coronaviruses polyprotein 1ab family | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Ligand Info |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7SET SARS-CoV-2 Main Protease (Mpro) in Complex with ML1000 | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [1] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSCGSVGF150 NIDYDCVSFC 160 YMHHMELPTG170 VHAGTDLEGN180 FYGPFVDRQT190 AQAAGTDTTI200 TVNVLAWLYA 210 AVINGDRWFL220 NRFTTTLNDF230 NLVAMKYNYE240 PLTQDHVDIL250 GPLSAQTGIA 260 VLDMCASLKE270 LLQNGMNGRT280 ILGSALLEDE290 FTPFDVVRQC300 SGVTFQ |
|||||
|
THR26
4.275
LEU27
4.421
HIS41
2.581
MET49
3.783
TYR54
3.676
PHE140
3.320
LEU141
3.785
ASN142
3.475
GLY143
2.805
SER144
3.042
CYS145
1.754
HIS163
2.742
HIS164
2.868
|
|||||
PDB ID: 7S6X Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI30 | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [2] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICNPNYED56 LLIRKSNHNF 66 LVQAGNVQLR76 VIGHSMQNCV86 LKLKVDTANP96 KTPKYKFVRI106 QPGQTFSVLA 116 CYNGSPSGVY126 QCAMRPNFTI136 KGSFLNGSCG146 SVGFNIDYDC156 VSFCYMHHME 166 LPTGVHAGTD176 LAGNFYGPFV186 DRQTAQAAGT196 DTTITVNVLA206 WLYAAVINGD 216 RWFLNRFTTT226 LNDFNLVAMK236 YNYEPLTQDH246 VDILGPLSAQ256 TGIAVLDMCA 266 SLKELLQNGM276 NGRTILGSAL286 LEDEFTPFDV296 VRQCSGVTFQ306 |
|||||
|
THR25
4.952
THR26
4.038
LEU27
4.260
HIS41
2.451
TYR54
3.972
PHE140
3.464
LEU141
4.124
ASN142
3.312
GLY143
2.787
SER144
2.908
CYS145
1.805
HIS163
2.579
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | SARS-CoV-2 Main Protease (Mpro) in Complex with ML1000 | ||||
REF 2 | A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals. Eur J Med Chem. 2022 Oct 5;240:114596. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.